Lifestyle
- regular exercise
- adequate sleep
- stress management
Monocytes
Monocyte count measures the number of monocytes present in the blood, reflecting the body's immune response and inflammatory status.
Reference ranges can vary slightly based on laboratory standards and population demographics.
Monocytes, abbreviated as MONO, are a type of white blood cell that plays a crucial role in the immune system. They are part of the body's first line of defense and are involved in the recognition and response to pathogens, as well as in the regulation of inflammation. Monocytes circulate in the bloodstream and can differentiate into macrophages or dendritic cells upon migrating into tissues, where they perform phagocytosis and antigen presentation. Clinically, monocytes are significant in diagnosing and monitoring various inflammatory and infectious diseases. Elevated monocyte levels can indicate chronic inflammation, infections, or hematological disorders, while low levels may suggest bone marrow suppression or certain autoimmune conditions. In the context of athletic performance and biohacking, monocyte levels can reflect the body's inflammatory status, which is crucial for recovery and overall health. However, interpreting monocyte levels requires consideration of various factors, such as time of day, recent physical activity, and underlying health conditions. Researchers have observed that monocyte counts can vary based on circadian rhythms and may be influenced by acute stressors or infections. Therefore, it is essential to consider these variables when assessing monocyte levels to avoid misinterpretation.
Klinische Bedeutung
Elevated monocyte levels may indicate chronic inflammation, infections, or hematological disorders. Reduced levels can suggest bone marrow suppression or certain autoimmune conditions.
Progressively rising monocyte levels may suggest worsening inflammation or infection; re-test in 4 weeks if outside optimal range.
Falling monocyte levels could indicate resolution of inflammation or effective treatment response.
Re-test Interval
4 weeks if outside optimal range
Note:
Consult a healthcare provider before making significant lifestyle or dietary changes, especially if underlying health conditions are present.
Monocyte levels may vary with circadian rhythms; consistent timing for tests is recommended.
Testing Frequency
Annually for healthy adults, more frequently if monitoring a specific condition.
Current research suggests that the optimal reference ranges and functional phenotypes of monocyte subsets, particularly in relation to chronic inflammation and disease states, remain poorly defined. Researchers have not yet established the precise confounders affecting monocyte behavior in various conditions, such as atherosclerosis and cancer. Additionally, clinical questions regarding the predictive value of specific monocyte subsets for disease progression and treatment response remain unanswered.
1,654
Total Citations
25
Human/RCT
3.6
Avg. Influence
2026
Latest
This review focused on the role of monocyte subsets in tuberculosis infection. Researchers highlighted differences in the frequency and function of monocyte subsets, suggesting their potential as biomarkers for disease persistence and response to infection.
This review discussed the heterogeneity of human monocytes and their role in disease. Researchers found that monocytes can be classified into classical, non-classical, and intermediate subpopulations, which may serve as biomarkers for various diseases. Understanding these subpopulations is crucial for elucidating monocyte function in health and disease.
This review focused on calprotectin, a biomarker produced by activated monocytes and neutrophils, in rheumatic diseases. Researchers noted its potential in monitoring disease activity and response to treatment, emphasizing its role as a candidate biomarker.
This study explored the role of immunosuppressive CD14+HLA-DRlo/neg monocytes in cancer therapy responses. Researchers observed that these monocytes contribute to immune suppression and negatively affect the efficacy of various immunotherapies, indicating their potential as biomarkers for treatment outcomes.
This study used single-cell RNA sequencing to identify gene signatures in monocytes from patients with acute respiratory distress syndrome (ARDS). Researchers found a proinflammatory gene expression profile in ARDS monocytes compared to those without ARDS. They identified 29 genes that could serve as potential biomarkers for ARDS risk.
This study examined how human cytomegalovirus (HCMV) alters monocyte biology to enhance viral spread. Researchers found that HCMV can induce monocyte survival and differentiation into macrophages, which support viral replication, highlighting a unique mechanism of viral persistence.
This study examined the role of monocyte chemoattractant protein-1 (CCL2) in psoriasis. Researchers found that CCL2 facilitates monocyte migration to inflamed skin, indicating its potential as a biomarker for monitoring psoriasis progression and guiding treatment strategies.
Researchers observed systemic immune changes in breast cancer patients, specifically dysregulated cytokine signaling in peripheral blood monocytes. This dysregulation was linked to the risk of future relapse, indicating the importance of monocyte signaling as a potential biomarker for monitoring cancer progression.
Researchers reviewed the heterogeneity of bovine peripheral blood monocytes and compared them to human monocytes. They found significant functional differences between species, suggesting that bovine monocyte subsets may serve as biomarkers for inflammatory responses in veterinary medicine.
Researchers found that monocytes/macrophages are crucial in the development of atherosclerosis, with a concept called 'trained immunity' influencing their activation. The study highlights that prior stimulation can enhance monocyte responses, suggesting that epigenetic reprogramming may be a target for future therapies against atherosclerosis.
Research publications about Monozyten over time
10totalLog lab results, track trends and optimize your biomarkers over time.
This page is for informational and research purposes only. All information is based on published scientific literature and does not constitute medical advice, diagnosis, or treatment recommendations. Many substances listed may not be approved for human use and may be subject to drug regulation laws (e.g., AMG in Germany, FDA in the US). PepStack does not encourage the use of any substance on humans. Always consult a qualified healthcare professional before making any health-related decisions. Use of this information is entirely at your own risk. PepStack assumes no liability for the accuracy, completeness, or timeliness of the content provided. Full disclaimer